The role of mitochondria in the dysfunction of oligodendrocyte lineage cells: implications for the pathogenesis of multiple sclerosis. (360G-Wellcome-078415_Z_05_Z)

£515,503

Objectives: To investigate the role of mitochondria in the dysfunction of oligodendrocyte lineage cells in multiple sclerosis (MS), I will determine the(1) presence of mitochondrial dysfunction at biochemical, protein and genetic levels in oligodendrocyte lineage cells in acute (pattern II and III), active and chronic MS lesions. (2) neuropathological features of inherited mitochondrial disorders with primary demyelination. (3) effects of mitochondrial DNA (mtDNA) abnormalities on the development, function and survival of oligodendrocyte lineage cells in vitro (MO3, HOG, Ntera2 and mouseES cells).Design: (1) Histochemistry and immunohistochemistry will be performed on post-mortem brain tissue from MS and mitochondrial disorders. (2)Molecular biology techniques (laser micro-dissection, real-time PCR and mtDNA sequencing) on dissected oligodendrocyte lineage cells from frozen MS tissue will be used to identify evidence of damaged mtDNA. (3) transmitochondrial hybrids containing inherited abnormal mtDNA and cell lines containing acquiredabnormal mtDNA (IFN-gamma and TNF induced) will be used in vitro to assess migration, proliferation, differentiation, myelination and survival using time-lapse microscopy, proliferation markers, electron microscopy for ultrastructure, immunocytochemistry for myelin proteins and apoptosis using flow cytometry.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 515503
Applicant Surname Mahad
Approval Committee Clinical Interview Committee
Award Date 2005-12-06T00:00:00+00:00
Financial Year 2005/06
Grant Programme: Title Intermediate Clinical Fellowship
Internal ID 078415/Z/05/Z
Lead Applicant Dr Don Mahad
Partnership Value 515503
Planned Dates: End Date 2012-02-14T00:00:00+00:00
Planned Dates: Start Date 2006-03-15T00:00:00+00:00
Recipient Org: Country United Kingdom
Region North East
Sponsor(s) Prof Sir Doug Turnbull